Nexgel Inc (NXGL) - Total Assets
Based on the latest financial reports, Nexgel Inc (NXGL) holds total assets worth $11.62 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Nexgel Inc shareholders equity for net asset value and shareholders' equity analysis.
Nexgel Inc - Total Assets Trend (2016–2024)
This chart illustrates how Nexgel Inc's total assets have evolved over time, based on quarterly financial data.
Nexgel Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Nexgel Inc's total assets of $11.62 Million consist of 46.6% current assets and 53.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 16.5% |
| Accounts Receivable | $933.00K | 8.5% |
| Inventory | $1.75 Million | 15.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $807.00K | 7.4% |
| Goodwill | $1.13 Million | 10.3% |
Asset Composition Trend (2016–2024)
This chart illustrates how Nexgel Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Nexgel Inc.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nexgel Inc's current assets represent 46.6% of total assets in 2024, an increase from 20.4% in 2016.
- Cash Position: Cash and equivalents constituted 16.5% of total assets in 2024, up from 0.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 15.9% of total assets.
Nexgel Inc Competitors by Total Assets
Key competitors of Nexgel Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.14 Billion |
|
Vizionfocus Inc.
TW:4771
|
Taiwan | NT$6.53 Billion |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Nexgel Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.69 | 1.51 | 0.27 |
| Quick Ratio | 1.08 | 0.93 | 0.10 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.29 Million | $1.56 Million | $-969.00K |
Nexgel Inc - Advanced Valuation Insights
This section examines the relationship between Nexgel Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.03 |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | 10.3% |
| Total Assets | $10.98 Million |
| Market Capitalization | $4.73 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nexgel Inc's assets below their book value (0.43x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Nexgel Inc's assets grew by 10.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Nexgel Inc (2016–2024)
The table below shows the annual total assets of Nexgel Inc from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $10.98 Million | +10.33% |
| 2023-12-31 | $9.96 Million | -3.88% |
| 2022-12-31 | $10.36 Million | -39.02% |
| 2021-12-31 | $16.98 Million | +652.46% |
| 2020-12-31 | $2.26 Million | +19.42% |
| 2019-12-31 | $1.89 Million | +155.75% |
| 2018-12-31 | $739.00K | -17.34% |
| 2017-12-31 | $894.00K | -29.10% |
| 2016-12-31 | $1.26 Million | -- |
About Nexgel Inc
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solut… Read more